摘要
目的:研究类风湿性关节炎(RA)患者血清IL-15、TNF-α的变化及其临床意义。方法:收集34例RA患者,以20例骨关节炎(OA)患者和30例健康体检者作对照。采用双抗体夹心酶联免疫吸附法测定血清IL-15、TNF-α的水平,并测定类风湿因子和C反应蛋白。结果:RA患者的血清IL-15、TNF-α的含量明显高于OA组及健康体检组(P<0.05),RA患者的类风湿因子明显高于对照组(P<0.05),C反应蛋白的含量在各组间差异无统计学意义;RA组中,血清IL-15、TNF-α水平明显相关(r=0.771)。结论:IL-15、TNF-α在RA患者的疾病发展过程中发挥着重要作用,阻断其生物活性,为靶向治疗RA患者提供了新思路。
Objective:To investigate the change of interleukin-15 and tumor necrosis factor-α levels in patients with rheumatoid arthritis(RA) and their clinical significance.Methods:34 patients with rheumatoid arthritis(RA group),20 patients with osteoarthritis(OA) and 30 healthy subjects(served as two control groups) were enrolled in the investigation.IL-15 and TNF-α levels were detected by double antibodies sandwich enzyme-linked immunosorbent assay(ELISA).The levels of rheumatoid factor and C-reactive protein were detected as well.Results:The level of IL-15,TNF-α and rheumatoid factor in RA patients were significantly higher than those in two control groups.In contract,the level of C-reactive protein in three groups showed no significant difference.The level of serum IL-15 significantly correlated with that of TNF-α in patients with RA(r=0.771).Conclusion:IL-15,TNF-α play an important role in the development of rheumatoid arthritis.Blocking the effects may give a new hope in treatment of RA.
出处
《中国卫生检验杂志》
CAS
2009年第12期2873-2874,共2页
Chinese Journal of Health Laboratory Technology